1.
Collins RL, Brand H, Karczewski KJ, et al. A structural variation reference for medical and population genetics. Nature. 2020;581(7809):444-451. doi:10.1038/s41586-020-2287-8.
Eric Lander
1.
Vallabh SM, Minikel EV, Schreiber SL, Lander ES. Towards a treatment for genetic prion disease: trials and biomarkers. Lancet Neurol. 2020;19(4):361-368. doi:10.1016/S1474-4422(19)30403-X.
1.
Ray JP, de Boer CG, Fulco CP, et al. Prioritizing disease and trait causal variants at the TNFAIP3 locus using functional and genomic features. Nat Commun. 2020;11(1):1237. doi:10.1038/s41467-020-15022-4.
1.
Dietlein F, Weghorn D, Taylor-Weiner A, et al. Identification of cancer driver genes based on nucleotide context. Nat Genet. 2020. doi:10.1038/s41588-019-0572-y.
1.
Painter CA, Jain E, Tomson BN, et al. The Angiosarcoma Project: enabling genomic and clinical discoveries in a rare cancer through patient-partnered research. Nat Med. 2020;26(2):181-187. doi:10.1038/s41591-019-0749-z.
1.
Basak A, Munschauer M, Lareau CA, et al. Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation. Nat Genet. 2020. doi:10.1038/s41588-019-0568-7.
1.
Fulco CP, Nasser J, Jones TR, et al. Activity-by-contact model of enhancer-promoter regulation from thousands of CRISPR perturbations. Nat Genet. 2019;51(12):1664-1669. doi:10.1038/s41588-019-0538-0.
1.
Khera AV, Mason-Suares H, Brockman D, et al. Rare Genetic Variants Associated With Sudden Cardiac Death in Adults. J Am Coll Cardiol. 2019;74(21):2623-2634. doi:10.1016/j.jacc.2019.08.1060.
1.
Holtzman SH, Cohen R, Levin JM, Maraganore J, Signatories to the Statement. Chinese scientists and US leadership in the life sciences. Nat Biotechnol. 2019;37(11):1261-1263. doi:10.1038/s41587-019-0285-x.
1.
Hoch E, Florez JC, Lander ES, Jacobs SBR. Gain-of-Function Claims for Type-2-Diabetes-Associated Coding Variants in SLC16A11 Are Not Supported by the Experimental Data. Cell Rep. 2019;29(3):778-780. doi:10.1016/j.celrep.2019.09.021.